D. Kessler, R. Merkatz, and R. Schapiro, A Call for Higher Standards for Breast Implants, JAMA: The Journal of the American Medical Association, vol.270, issue.21, pp.2607-2608, 1993.
DOI : 10.1001/jama.1993.03510210093034

I. Ariel, J. Cleary, and E. , Breast Cancer -Diagnosis and Treatment, 1987.

A. Patchefsky, G. Schwartz, and S. Finkelstein, Heterogeneity of intraductai carcinoma of the breast, Cancer, vol.2, issue.4, pp.731-741, 1989.
DOI : 10.1002/1097-0142(19890215)63:4<731::AID-CNCR2820630422>3.0.CO;2-#

L. Solin, A. Fourquet, and B. Mccormick, Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (Intraductal Carcinoma) of the breast, International Journal of Radiation Oncology*Biology*Physics, vol.30, issue.1, pp.3-9, 1994.
DOI : 10.1016/0360-3016(94)90512-6

L. Solin, I. Yeh, and J. Kurtz, Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment, Cancer, vol.28, issue.8, pp.2532-2542, 1993.
DOI : 10.1002/1097-0142(19930415)71:8<2532::AID-CNCR2820710817>3.0.CO;2-0

M. Silverstein, E. Gierson, and W. Colburn, Axillary lymphadenectomy for intraductal carcinoma of the breast, Surgery, Gynecology and Obstetrics, vol.172, issue.3, pp.211-214, 1991.

G. Schwartz, The role of excision and surveillance alone in subclinical DCIS of the breast, Oncology (Huntington NY), vol.8, issue.2, pp.21-35, 1994.

J. Boice, E. Harvey, and M. Blettner, Cancer in the Contralateral Breast after Radiotherapy for Breast Cancer, New England Journal of Medicine, vol.326, issue.12, pp.781-785, 1992.
DOI : 10.1056/NEJM199203193261201

B. Fraass, P. Roberson, and A. Lichter, Dose to the contralateral breast due to primary breast irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.11, issue.3, pp.485-497, 1985.
DOI : 10.1016/0360-3016(85)90179-8

S. Orel, R. Troupin, and E. Patterson, Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection., Radiology, vol.183, issue.1, pp.201-206, 1992.
DOI : 10.1148/radiology.183.1.1312733

E. Frykberg, F. Santiago, and W. Betsill, Lobular Carcinoma In Situ of the Breast, The Breast Journal, vol.127, issue.5, pp.285-301, 1987.
DOI : 10.1002/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.3.CO;2-R

S. Ciatto, L. Cataliotti, and G. Cardona, Risk of infiltrating breast cancer subsequent to lobular carcinoma in situ, Tumori, vol.78, issue.4, pp.244-246, 1992.

N. Wolmark, Adjuvant Breast and Bowel Project: Randomized, Placebo-Controlled Clinical Trial to Determine the Worth of TMX for Preventing Breast Cancer (Summary Last Modified 11/94), NSABP-P-1, clinical trial, active, p.4

A. Stotter, M. Mcneese, and M. Oswald, The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.18, issue.2, pp.283-287, 1990.
DOI : 10.1016/0360-3016(90)90090-7

B. Bornstein, A. Recht, and J. Connolly, Results of treating ductal carcinomaIn situ of the breast with conservative surgery and radiation therapy, Cancer, vol.2, issue.1, pp.7-13, 1991.
DOI : 10.1002/1097-0142(19910101)67:1<7::AID-CNCR2820670103>3.0.CO;2-B

B. Mccormick, P. Rosen, and D. Kinne, Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.289-292, 1991.
DOI : 10.1016/0360-3016(91)90773-W

M. Silverstein, J. Waisman, and E. Gierson, Radiation therapy for intraductal carcinoma. Is it BRCA2, to chromosome 13q12-13, Science, vol.265, issue.5181, pp.2088-2090, 1994.

B. Biesecker, M. Boehnke, and K. Calzone, Genetic Counseling for Families With Inherited Susceptibility to Breast and Ovarian Cancer, JAMA: The Journal of the American Medical Association, vol.269, issue.15, pp.1970-1974, 1993.
DOI : 10.1001/jama.1993.03500150082032

J. Hall, M. Lee, and B. Newman, Linkage of early-onset familial breast cancer to chromosome 17q21, Science, vol.250, issue.4988, pp.1684-1689, 1990.
DOI : 10.1126/science.2270482

D. Easton, D. Bishop, and D. Ford, Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families, American Journal of Human Genetics, vol.52, pp.678-701, 1993.

B. Fisher, E. Fisher, and C. Redmond, Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer, Breast Cancer Research and Treatment, vol.75, issue.3, pp.147-160, 1986.
DOI : 10.1007/BF01806245

E. Jensen, E. Desombre, J. Holland, E. Frei, and R. Bast, Steroid hormone binding and hormone receptors, Cancer Medicine. Philadelphia: Lea & Febiger, pp.815-823, 1993.

B. Fisher, C. Osborne, and R. Margolese, Neoplasms of the breast, Cancer Medicine. Philadelphia: Lea & Febiger, pp.1706-1716, 1993.

F. Holmes, H. Fritsche, and J. Loewy, Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay., Journal of Clinical Oncology, vol.8, issue.6, pp.1025-1035, 1990.
DOI : 10.1200/JCO.1990.8.6.1025

E. Fisher, C. Redmond, and B. Fisher, Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients, Cancer, vol.100, issue.S9, pp.2121-2128, 1990.
DOI : 10.1002/1097-0142(19900501)65:9+<2121::AID-CNCR2820651408>3.0.CO;2-M

N. Cascinelli, M. Greco, and R. Bufalino, Prognosis of breast cancer with axillary node metastases after surgical treatment only, European Journal of Cancer and Clinical Oncology, vol.23, issue.6, pp.795-799, 1987.
DOI : 10.1016/0277-5379(87)90281-1

S. Moot, G. Peters, and J. Cheek, Tumor hormone receptor status and recurrences in premenopausal node negative breast carcinoma, Cancer, vol.309, issue.3, pp.382-385, 1987.
DOI : 10.1002/1097-0142(19870801)60:3<382::AID-CNCR2820600316>3.0.CO;2-J

P. Rosen, S. Groshen, and D. Kinne, Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study., Journal of Clinical Oncology, vol.9, issue.9, pp.1650-1661, 1991.
DOI : 10.1200/JCO.1991.9.9.1650

A. Tandon, G. Clark, and G. Chamness, Cathepsin D and Prognosis in Breast Cancer, New England Journal of Medicine, vol.322, issue.5, pp.297-302, 1990.
DOI : 10.1056/NEJM199002013220504

P. Rosen, S. Groshen, and D. Kinne, Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up., Journal of Clinical Oncology, vol.11, issue.11, pp.2090-2100, 1993.
DOI : 10.1200/JCO.1993.11.11.2090

B. Davis, R. Gelber, and A. Goldhirsch, Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis, Cancer, vol.2, issue.12, pp.2662-2670, 1986.
DOI : 10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO;2-Y

S. Friedman, F. Bertin, and H. Mouriesse, Importance of Tumor Cells in Axillary Node Sinus Margins (???Clandestine??? Metastases) Discovered by Serial Sectioning in Operable Breast Carcinoma, Acta Oncologica, vol.45, issue.5, pp.483-487, 1988.
DOI : 10.1097/00000658-198111000-00005

S. Orel, M. Schnall, and V. Livolsi, Suspicious breast lesions: MR imaging with radiologic-pathologic correlation., Radiology, vol.190, issue.2, pp.485-493, 1994.
DOI : 10.1148/radiology.190.2.8284404

A. De-la-rochefordiere, B. Asselain, and F. Campana, Age as prognostic factor in premenopausal breast carcinoma*1, The Lancet, vol.341, issue.8852, pp.1039-1043, 1993.
DOI : 10.1016/0140-6736(93)92407-K

K. Gilchrist, R. Gray, and B. Fowble, Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients., Journal of Clinical Oncology, vol.11, issue.10, pp.1929-1935, 1993.
DOI : 10.1200/JCO.1993.11.10.1929

J. Bastarrachea, G. Hortobagyi, and T. Smith, Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer, Annals of Internal Medicine, vol.120, issue.1, pp.18-25, 1994.
DOI : 10.7326/0003-4819-120-1-199401010-00004

R. Elledge, G. Clark, and G. Chamness, Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States, JNCI Journal of the National Cancer Institute, vol.86, issue.9, pp.705-712, 1994.
DOI : 10.1093/jnci/86.9.705

E. Claus, N. Risch, and W. Thompson, Autosomal Dominant Inheritance of Early-Onset Breast Cancer, Obstetrical & Gynecological Survey, vol.49, issue.6, pp.643-651, 1994.
DOI : 10.1097/00006254-199406000-00016

M. Gail, L. Brinton, and D. Byar, Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually, JNCI Journal of the National Cancer Institute, vol.81, issue.24, pp.1879-1886, 1989.
DOI : 10.1093/jnci/81.24.1879

Y. Miki, J. Swensen, and D. Shattuck-eidens, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994.
DOI : 10.1126/science.7545954

R. Wooster, S. Neuhausen, and J. Mangion, Localization of a breast cancer susceptibility gene, 5 References 5.1 References used in this technical report

B. Fisher, M. Bauer, D. L. Wickerham, C. K. Redmond, and E. R. Fisher, Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, vol.152, issue.9, pp.1551-1557, 1983.
DOI : 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3

G. Bonadonna and P. Valagussa, Adjuvant systemic therapy for resectable breast cancer., Journal of Clinical Oncology, vol.3, issue.2, pp.727-742, 1989.
DOI : 10.1200/JCO.1985.3.2.259

K. I. Pritchard, Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?, Annals of Internal Medicine, vol.111, issue.1, pp.1-4, 1989.
DOI : 10.7326/0003-4819-111-1-1

C. K. Osborne, V. T. De-vita, . Jr, S. Hellman, S. A. Rosenberg et al., Prognostic factors in breast cancer Principles and practise of oncology, pp.1-11, 1990.

B. Fisher, C. Redmond, and E. R. Fisher, Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06., Journal of Clinical Oncology, vol.6, issue.7, pp.1076-1087, 1988.
DOI : 10.1200/JCO.1988.6.7.1076

S. S. Bacus, C. R. Zelnick, G. Plowman, and Y. Yarden, Expression of the erbB-2 family of growth and their ligands in breast cancer, American Journal of Clinical Pathology, vol.102, issue.4, pp.13-23, 1994.

J. L. Upadhyay, B. N. Ghosh, and I. N. Sengupta, International channel of communication for breast cancer literature, International Information, Communication and Education, vol.10, issue.1, pp.48-59, 1991.

D. A. Norman, The psycology of everyday things (Basic Books, 1988.

E. Shortliffe, A. Scott, M. Bischoff, C. Van-melleand, and W. Jacobs, ONCOCIN: An expert system for oncology protocol management, Proceedings IJCAI81, pp.876-881, 1981.

S. W. Tu, M. G. Kahn, M. A. Musen, J. C. Ferguson, E. H. Shortliffe et al., Episodic skeletal-plan refinement based on temporal data, Communications of the ACM, vol.32, issue.12, pp.1439-1455, 1989.
DOI : 10.1145/76380.76384

S. Gaglio, C. Ruggiero, G. Spinelli, G. Bonadonna, P. Valagussa et al., BREASTCAN: An expert system for postoperative breast cancer therapy, Computers and Biomedical Research, vol.19, issue.5, 1986.
DOI : 10.1016/0010-4809(86)90039-X

M. The, 14 3.3.1 Definition of prognosis17 3.3.2 Decomposition of prognosis in generic tasks, p.26

C. Future-developments, 30 4.1 A conceptual information retrieval system for the production of guidelines on prognostic factors of breast cancer, p.30

D. Appendix, 78 9.1 Attended courses and pubblication produced in relation to this work, p.78